Abbott announced that it will cut 1,900 positions in a restructuring exercise intended to streamline commercial and manufacturing operations. Sales jobs are one of the target areas for the cuts, according to Scott Stoffel, and Abbott spokesperson. The cost-cutting measures will take place “primarily in the US,” said Stoffel. Miles White, chairman and CEO at Abbott, cited European pricing pressures and a regulatory environment that “says no more than it says yes,” as reasons for the cuts.
Aqua Pharmaceuticals appointed Ted White to VP, sales. White’s responsibilities include managing Aqua’s “rapidly growing sales force,” according to a company announcement. White joins Aqua from Novartis, where he worked as managing director. Aqua is a specialty pharma focused on dermatology products.
Clinical Data will launch Viibryd, a depression medication, during the second quarter of 2011. The brand received FDA approval on January 21, and 150 sales reps will target psychiatrists and high-prescribing primary care physicians at launch, Drew Fromkin, CEO and president at Clinical Data, told MM&M. Clinical Data reps will “more likely…focus on the specialty psychiatry side, and hope to expand through other relationships on the primary care side,” said Fromkin.
From the March 01, 2011 Issue of MM+M - Medical Marketing and Media
